Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0000947871-17-000256
Filing Date
2017-03-28
Accepted
2017-03-28 18:54:43
Documents
1
Period of Report
2017-03-27

Document Format Files

Seq Description Document Type Size
1 OWNERSHIP DOCUMENT ss36711_4.html 4  
1 OWNERSHIP DOCUMENT ss36711_4.xml 4 5323
  Complete submission text file 0000947871-17-000256.txt   6973
Mailing Address C/O ANTHERA PHARMACEUTICALS, INC. 25801 INDUSTRIAL BOULEVARD, SUITE B HAYWARD CA 94545
Business Address
Thompson Peter A. (Reporting) CIK: 0001357522 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-37368 | Film No.: 17720342

Mailing Address 101 PARK DRIVE MILTON PARK ABINGDON, OXFORDSHIRE X0 OX14 4RY
Business Address 101 PARK DRIVE MILTON PARK ABINGDON, OXFORDSHIRE X0 OX14 4RY 44 1235 430000
Adaptimmune Therapeutics PLC (Issuer) CIK: 0001621227 (see all company filings)

EIN.: 000000000 | State of Incorp.: X0 | Fiscal Year End: 0630
SIC: 2836 Biological Products, (No Diagnostic Substances)